Genomic Medicine Alliance News
- Saturday, 05 November 2016
The 2016 Golden Helix Summer School with the theme "Cancer Genomics and Individualized Therapy" was successfully organized at the Dolphin Bay Resort hotel in Syros island, Greece, 22-26 September 2016. The meeting was attended by 90 participants, guest speakers and company representatives from more than 20 countries worldwide, such as Greece and also the United States, United Kingdom, United Arab Emirates, Ecuador, Korea, China, Slovenia, Italy, Germany, the Netherlands, Ireland, etc.
Guest speakers presented their work about emerging topics in the field of Cancer Genomics, such as cancer diagnostics using whole genome sequencing, pharmacogenomics and treatment individualization, economics in genomics, public health genomics, etc. Also, company representatives presented interesting lectures about Pharmacogenovigilance and liquid biopsies. The keynote lecture was delivered on Monday September 26th, 2016 by Professor Magnus Ingelman Sundberg (Karolinska Institute, Sweden) and member (since 2008) of the Nobel Assembly. Like the previous Summer School in 2014, the 2016 Golden Helix Summer School included a career development session, coordinated by Professor Jurgen Reinchardt (Ecuador), two interactive sessions (organized by Professors Alessio Squassina and George Patrinos) and two workshops on in silico drug design and pharmacometabolomics (delivered by Dr Theodora Katsila and Minos Matsoukas).
Most importantly, the 2016 Golden Helix Summer School organized a special event specifically aimed for the general public, in line to the aims and goals of the Golden Helix Foundation to increase the general public genomics awareness. There was also a guided tour to Ermoupolis, where participants had the chance to admire the landmark buildings of Ermoupolis, such as the Town Hall, the Opera house and the neoclassic buildings, while the various social events, the farewell dinner with traditional dances from the Lyceum Club of Greek women and the recreational time in between the scientific sessions gave the opportunity to strengthen collaboration ties among the faculty members and to the Summer School participants to meet with the internationally renowned faculty, many of which arranged short term visits and trainings.
Overall, the 2016 Golden Helix Summer School was a success and according to the current planning, the 2018 Golden Helix Summer School will be organized again in Syros island in September 2018 with the theme revolving around Rare Diseases, Rare Cancers and Rare Drug Outcomes.
Please visit the 2016 Golden Helix Summer School website to access the photo gallery and downloads.
- Tuesday, 03 May 2016
The Genomic Medicine Alliance proudly announces the formation of the DRIFT Consortium with Regeneron Genetics Center (RGC). The DRIFT (Discovery Research Investigating Founder Population Traits) Consortium is an open call for research collaboration to understand the genetic architecture of founder populations throughout the world to impact health and disease.
With this agreement, academic institutions and research centers from developing countries and resource-limited environments will be given a unique opportunity to engage into advanced genomics research to elucidate the underlying genetic etiology of rare diseases in their population FREE-OF-CHARGE.
DRIFT is planning two tiers of collaboration models (see details below). For both models, we intend to broadly share data and results with the research community. If exciting new results are generated from a Tier 1 or Tier 2 collaboration, there will be potential for the design and funding of follow-up “genotype-first call-back” studies for additional collaborative research to delve more deeply into biological mechanisms and pathways. Participating academic institutions and research centers from developing countries will provide the RGC de-identified DNA samples with (Tier-2) or without (Tier-1) phenotypic information. RGC will provide these centers whole exome sequencing and genome-wide association (with phenotype, where applicable) data free-of-charge. Data analyses of the combined genotype-phenotype data (where applicable) will be performed collaboratively and each party will be free to: (i) use these datasets for its internal research; (ii) publish results; (iii) use published results for any and all purposes.
For further inquiries and information for participation, please contact:
Click here to read the full announcement published in Public Health Genomics, the Official journal of the Genomic Medicine Alliance
- Thursday, 14 April 2016
The Genomic Medicine Alliance proudly announces the organization of the 2016 Golden Helix Summer School in the island of Syros, Greece, September 22-26, 2016. The theme of the meeting will be "Cancer Genomics and Individualized Therapy" and will include plenary lectures by over 24 local and international speakers coming from Europe and the United States.
The 2016 Golden Helix Summer School will also include a Science night that will be open to the public, where local speakers will give state-of-the-art lectures on recent developments on cancer treatment and prevention. As with the previous event, the 2016 Golden Helix Summer School will feature a career development sessions, flash talks of the best abstracts, and interactive and poster sessions.
ALL abstracts submitted for presentation at the 2016 Golden Helix Summer School will be published in a Supplementary issue of Public Health Genomics, the official journal of the Genomic Medicine Alliance.
Please visit the 2016 Golden Helix Summer School website to access the scientific program and to register for the event.
Workshop: 16th Golden Helix Pharmacogenomics Day at Festival of Genomics Boston in June 22nd 2015, 16:00-19:00
- Friday, 08 May 2015
The 16th Golden Helix Pharmacogenomics Day is an educational event that aims to provide timely updates on the field of pharmacogenomics and personalized medicine to the local biomedical scientists and healthcare providers, to inform them on the application of pharmacogenomics in fields such as psychiatric disorders, oncology, and to bring together faculty members from universities and research institutes from the local scientific arena working in the field of pharmacogenomics in order to initiate collaborative projects in this field to the benefit of society.
This workshop will include:
- Lectures by 6 speakers from the US, both from academia, industry and regulatory (NIH) backgrounds.
- Topics will pertain to pharmacogenomics and personalized medicine
- The Global Genomic Medicine Collaborative and the Genomic Medicine Alliance initiatives will be highlighted.
What will participants take away from this workshop?
- The most recent trends on pharmacogenomics
- The aims and goals of the Global Genomic Medicine Collaborative and the Genomic Medicine Alliance Initiatives
- Collaboration and training opportunities with the faculty of the workshop
George P. Patrinos, University of Patras Department of Pharmacy, Patras, Greece
Konstantinos Mitropoulos, the Golden Helix Foundation, London, UK
- Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
- Federico Innocenti, Associate Professor, University of North Carolina, Chapel Hill, NC, USA
- Alan R. Shuldiner, Vice President, Translational Genetics, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
- Marc S. Williams, Director, Genomic Medicine Institute, Geisinger Health System, Danville, PA,USA
- George P. Patrinos, Associate Professor, University of Patras Department of Pharmacy, Patras, Greece
- Deepak Voora, Assistant Professor, Duke Center for Genomic and Computational Biology, Durham, NC, USA
Enter promo code: Helix25 and get 25% off at registration.